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Abstract 
Marginal structural models (MSMs) are commonly used to estimate causal intervention effects in 
longitudinal non-randomised studies. A common challenge when using MSMs to analyse observational 
studies is incomplete confounder data, where a poorly informed analysis method will lead to biased 
intervention effect estimates. Despite a number of approaches described in the literature to handle 
missing data in MSMs, there is little guidance on what works in practice and why. We reviewed existing 
missing data methods for MSMs and discussed the plausibility of their underlying assumptions. We also 
performed realistic simulations to quantify the bias of five methods used in practice: complete case 
analysis, the last observation carried forward, the missingness pattern approach, multiple imputation 
and inverse-probability-of-missingness weighting. We considered three mechanisms for non-monotone 
missing data encountered in electronic health record data research. Further illustration of the strengths 
and limitations of these analysis methods are provided through an application using a cohort of 
individuals with sleep apnoea, the research database of the French “Observatoire Sommeil de la 
Fédération de Pneumologie” (OSFP). We recommend a careful consideration of (i) the reasons for 
missingness, (ii) whether missingness modifies the existing relationships among observed data and (iii) 
the scientific context and data source, to inform the choice of the appropriate method(s) to handle 
partially observed confounders in MSMs.  
Keywords: time-varying confounding; propensity score; multiple imputation; inverse probability 
weighting; missingness pattern approach; last observation carried forward; complete cases. 
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List of abbreviations: CC: Complete Case; CPAP: Continuous Positive Airway Pressure; IPMW: Inverse 
Probability of Missingness Weighting; LOCF: Last Observation Carried Forward; MAR: Missing At 
Random; MCAR: Missing Completely At Random; MNAR: Missing Not At Random; MSM: Marginal 
Structural Model; MI: Multiple Imputation; MPA: Missingness Pattern Approach;  
BACKGROUND 
Although randomised trials are the gold standard to establish causal effects of treatments and non-
pharmacological interventions on health outcomes, observational data are increasingly used for causal 
inference (1). The enormous potential offered by the wealth of routinely collected medical data 
available and the need for real-world evidence to assess the efficacy and safety of treatments have 
contributed to this phenomenon.  
These routinely collected data typically have a longitudinal structure, following individuals over time, 
allowing the measurement of dynamic treatment patterns, including treatment switching or delay to 
treatment initiation. Patients with chronic conditions often have a non-linear treatment history: 
treatment prescription might be updated based on the occurrence of new health events, changes in 
individual factors or side-effects induced by previous treatments. The newly prescribed treatment 
might, in turn, affect future health events and individual factors, themselves potentially associated with 
the outcome of interest (2). In such settings, specific statistical methods are required to account for 
confounding bias induced by time-varying variables (3). Indeed, adjusting for the confounders and 
treatment history is not sufficient, and often leads to biased estimates of the causal treatment effects 
(4). This is because the effect of a treatment received at a specific time on the outcome is mediated by 
subsequent treatments. Propensity scores - the individual probabilities of receiving the treatment of 
interest conditionally on individual characteristics - have been extended to situations with time-varying 
treatment and confounders (5), with scores estimated at each time point (6).  The cumulative product of 
the inverse of these scores over time can be used as a weight to account for confounding in the 
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estimation of the treatment effect in a marginal structural model (MSM) (7). This method of adjusting 
for time-varying confounders is by far the most common in practice (8). 
A challenge when analysing observational data is incomplete confounder information. In routinely 
collected data, missingness is particularly prevalent on covariates. This can happen if some information 
is not recorded at a given time point or the frequency of the measurement varies from one patient to 
another (e.g. asynchronous medical visits (9)). This might jeopardize the validity of the results if the issue 
is ignored in the analysis, depending on the underlying missingness mechanisms. In practice, despite the 
STROBE recommendations to report the amount of missing data and the way they are handled (10) in 
observational studies, reporting is often suboptimal. A review of reporting of missing exposure data in a 
longitudinal cohort showed that 43% of identified publications adhered to these guidelines (11). 
Importantly, when the method for handling missing data was reported, it was often done using 
inadequate methods. Although several methods to handle missing data on covariates have been used in 
the context of time-varying exposures (11), the most common approaches – complete case (CC) analysis 
and last observation carried forward (LOCF) – have been criticized. Use of more complex approaches 
such as multiple imputation (MI) or inverse-probability of-missingness-weighting (IPMW) have been 
suggested, but their performance is yet to be fully explored. Another promising approach, which has not 
been extended to the context of MSMs, is the missingness pattern approach (MPA). 
To our knowledge, there are no published guidelines for the choice of methods to handle missing 
confounder data in MSMs. Published studies on missing data in MSMs focused on missing data in the 
exposure (11,12) or compared the performances of a few methods only (13,14). Moodie et al. (14) 
compared the use of IPMW and MI, finding that MI outperformed IPMW, but they did not investigate 
the performance of MPA and LOCF. Moreover, only one covariate and two time points were considered, 
limiting the generalisability of the results. Vourli and Touloumi (15) investigated the performance of MI, 
IPMW and LOCF but found opposite conclusions in their setting, finding that IPMW usually performed 
better than MI. This might be explained by the omission of the outcome from the imputation model. A 
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recent plasmode simulation (13) suggested superiority of MI over IPMW, but surprisingly, CC analysis 
was the least biased. A limitation of these published studies is their focus on missingness mechanisms 
described under Rubin’s taxonomy of missing data (16); this taxonomy may be too restrictive to describe 
complex missingness scenarios encountered in routinely collected data (17).  
The aims of this paper are, first, to provide an overview of existing methods to handle missing data on 
confounders in MSMs and, second, to recommend practical guidelines. These guidelines will rely on the 
understanding of the assumptions and missingness mechanisms under which these methods are valid. 
We focus on situations where some variables are not recorded during the visit, rather than missing data 
introduced because of sparse follow-up. These two scenarios differ both in terms of underlying 
missingness mechanisms and required statistical methods. The challenges of sparse follow-up has been 
discussed by Mojaverian et al. (9) and Kreif et al. (18). We present a simulation study comparing the 
performance of CC analysis, LOCF, MI, IPMW and MPA to handle partially observed confounders under 
common missingness mechanisms encountered in observational studies. Finally, we illustrate the 
implementation of these methods by investigating the impact of observance to treatment on sleepiness 
in patients with sleep apnoea. 
 
CAUSAL INFERENCE IN THE PRESENCE OF TIME-VARYING TREATMENT AND CONFOUNDERS 
When time-varying confounding occurs, standard regression approaches fail because of treatment-
confounder feedback (19), even when past treatment and confounders values are adjusted for (3). 
MSMs were developed (7) to estimate causal effects in this setting. MSMs rely on an extension of 
inverse-probability-of-treatment weighting, a propensity score approach, for multiple time points. 
Details about this framework and underlying assumptions for a single time point are in Web Appendix 1. 
Similar to propensity score approaches, MSMs are a two-stage process. In the first stage, (19), weights – 
based on the inverse of the probability of a patient receiving the treatment they actually received – are 
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estimated to create a pseudo-population in which treatment and confounders are independent. In the 
second stage, a weighted regression (using the weights derived in the first stage) including only the 
treatment history can be used to obtain estimate the causal effect of the treatment regimens of 
interest. Under the assumptions of no interference, consistency, exchangeability and positivity extended 
to time-varying settings, and assuming the model used to obtain the weights is correctly specified, 
MSMs lead to unbiased estimates of the marginal causal effect of the treatment regimen.  
In practice, the weights can be estimated using pooled logistic regression (6), in which each person-time 
interval is considered as an observation. This pooled logistic regression model must include the 
confounders and their relevant interactions to ensure the distributions of confounders are balanced 
between treatment groups in the weighted pseudo-population at each time point. Further details about 
the implementation of MSMs can be found in Web Appendix 2. 
MISSING DATA IN MSMs: mechanisms and methods 
The choice of an appropriate missing data method relies on the characterization of the missingness 
patterns and the missingness mechanisms. The missingness patterns simply define which values of the 
covariates are observed and which are missing. For example, if the dataset contains only two time-fixed 
covariates L1 and L2, there are four missing data patterns: L1 and L2 can be both observed, both 
missing, L1 can be observed and L2 missing, or L1 can be missing and L2 observed. Similarly, if L1 and L2 
are measured at two time-points, there are 16 patterns. Some methods for handling missing data, such 
as multiple imputation, apply to any pattern of missing data; other methods apply only to specific 
structures of missing data, the most common being the monotone missing data pattern. In longitudinal 
data, monotone missingness patterns occur when, once a patient has a missing observation at one time 
point, values for all subsequent time points are also missing. This is typically what happens when 
patients are lost to follow-up. Whereas methods based on inverse weighting have been proposed to 
address this type of missing data in MSMs, there is no guidance on how to handle arbitrary patterns (not 
monotone) in MSMs. This is however the most common pattern found in routinely collected data where 
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data are not collected for research purposes, and the quality of recording may vary from one visit to 
another. 
Little and Rubin’s classification is often used to classify the missing data as being (i) missing completely 
at random (MCAR) when the probability of data being missing does not depend on the observed or 
unobserved data, (ii) missing at random (MAR) if the probability of data being missing does not depend 
on the unobserved data, conditional on the observed data or (iii) missing not at random (MNAR) if the 
probability of data being missing depends on the unobserved data, even after conditioning on the 
observed data (20).  
A variety of methods to handle missing data on covariates have been used in the context of time-varying 
exposures (11). The most common approach is complete case (CC) analysis, in which only patients with a 
complete record for all the covariates are included in the analysis. Another simple and popular approach 
is the last observation carried forward (LOCF): when a measurement is missing, the most recent past 
value observed for this patient is used to impute the missing value. Multiple imputation (MI) uses 
relationships existing among the observed variables to draw multiple times plausible values for the 
missing data; the standard error of the treatment effect estimates accounts for the uncertainty in these 
predictions. In MSMs, Robins and Hernán proposed to use censoring weights to account for patients lost 
to follow-up. Complete cases are re-weighted by the inverse of their probability of remaining in the 
study. Loss to follow-up can be viewed as a missing data problem, and therefore, these weights can be 
accommodated to account for missing data. This method is called inverse-probability of-missingness-
weighting (IPMW). Another promising approach to handle partially observed confounders that should 
be extended to MSMs is the missingness pattern approach (MPA). The MPA has been proposed for the 
estimation of propensity score weights in studies with a single time point (17). The sample is split into 
subgroups of patients having missing information on the same set of covariates and the weights are 
derived in each subgroup from the covariates available in that pattern. More details of these methods 
are in Web Appendix 3. The approaches rely on different assumptions; their validity depends on the 
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missingness mechanisms in the data at hand. These assumptions along with the strengths and 
limitations of each method are summarised in Table 1. 
METHODS 
We performed a simulation study to (i) illustrate the impact on bias of violations of the assumptions 
required for each method to be valid, and the relative precision of these methods when assumptions 
hold and (ii) highlight existing challenges in their implementation in practice. Data were simulated to 
mimic an observational study looking at the effect of a time-varying binary treatment on a continuous 
outcome, in the presence of time-varying confounding. We focused on four plausible types of 
missingness mechanisms (Figure 1): 
- MCAR mechanism: missingness is not dependent on either observed or unobserved variables 
- MAR mechanism: we consider 3 situations in which missing data depends on observed past 
treatment and confounder values (MAR|A,L), past treatment and confounder values and 
outcome (MAR|A,L,Y) or considering an association between missingness and the outcome 
introduced through the independent risk factor (MAR|A,L,V). 
- “Constant” mechanism: confounder values are missing if they have remained constant since the 
last visit (a mechanism under which LOCF is expected to perform well).  
- “Differential” mechanism: the missingness mechanism itself is MAR, but missingness affects the 
subsequent association between the true value of the confounder, and the treatment (the 
mechanism implicitly assumed by the MPA). In other words, the past observed values of the 
confounders and treatment predict missingness, but among individuals with a missing covariate 
value at a given time point, there is no association between the true (but unmeasured) value 
and the subsequent treatment received.  
We compared the performance of CC analysis, LOCF, MPA, MI and IPMW to estimate the causal effect of 
the intervention at each time point. The analysis model was the additive model proposed in (3,7): 
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                     , 
Where Y is a continuous outcome, ak are the binary treatment indicators at time k (k=0,1,2) and the β 
coefficients are the parameters of the marginal structural MSM. This model allows the estimation of the 
contrast between any treatment strategy of interest. The data-generating mechanisms, methods, 
estimands and performance measures for our simulations are presented in Web Appendix 4 and the R 
code to generate the data is available in Web Appendix 5. In the main scenario, the proportion of 
missing data was around 40%, and the sample size was n=10,000. We also investigated the impact of a 
smaller proportion of missing data (5%) and smaller sample size (n=500).  
RESULTS 
The results of the main simulation study (n=10,000 and 40% of missing data) are presented as boxplots 
(Figures 2-3), showing the distribution of the absolute bias for each method, and summarised in Table 1. 
Full results are presented in Web Tables 1- 5 and Web Figures 1-4.  
MCAR 
Whereas CC, MI and IPMW lead to unbiased estimates at the three time points, the MPA estimates are 
biased at each time point and LOCF estimates are biased at times 1 and 2 (Figure 2). The bias for the 
MPA arises from the direct associations existing between the confounders and the treatment allocation 
at subsequent time points even among participants with missing covariate values. For LOCF, the bias 
arises because the missing values were generally different from the observed previous value because 
confounder values were affected by prior treatment.  
MAR 
Except MI, which led to unbiased estimates at each time point for the three MAR scenarios, the 
performance of the other analysis strategies relied on the variables that were predictive of missingness 
(Figure 3). When missingness depended on the values of past treatment assignment and confounders, 
OR
IG
IN
AL
 U
NE
DI
TE
D
MA
NU
SC
RI
PT Downloaded from
 https://academ
ic.oup.com
/aje/advance-article/doi/10.1093/aje/kw
aa225/5923802 by guest on 30 O
ctober 2020
10 
 
IPMW estimates were unbiased at the three time points. A small bias was observed for complete case 
analysis and larger biases were obtained when using LOCF and MPA, for similar reasons as in MCAR 
scenarios. When the outcome was directly related to missingness, the only unbiased approached was 
MI. However, when an indirect association between the outcome and missingness existed, the IPMW 
led to unbiased estimates, but with a lower precision than MI.  
Missingness on constant values 
Only LOCF was unbiased (Figure 3) and the bias was worse with MI and IPMW than with CC. This is 
because they both use the existing relationships between the confounders, treatment and outcome in 
the observed data, but in this scenario, these relationships do not reflect the associations existing 
between the true (missing) confounder values and the other variables.  
Missingness affecting the subsequent covariate-treatment associations 
MPA was the only appropriate method to obtain unbiased treatment effect estimates, although the bias 
of the other approaches was quite small. As in the previous scenario, the associations between 
confounders and treatment among the complete cases cannot be used to make inferences about the 
relationship among participants with missing confounder values. Therefore, CC, MI and IPMW are 
biased. LOCF estimates are unbiased when missingness on a variable depends only on the previous 
measurement for that variable. However, in the current scenario, missingness depends on past values of 
the treatment and confounders.  
When the sample size was small (n=500), the magnitude of bias was similar to that observed for 
n=10,000, but the standard errors of the treatment effect estimates were very large, illustrating the lack 
of efficiency of MSMs in small samples (Web Figures 3-4).  
When only 5% of the data were missing, biases were smaller in magnitude and were, in our setting, 
negligible for non-MAR situations. However, we would not recommend the implementation of a method 
known to be biased when unbiased alternatives exist. 
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ILLUSTRATIVE EXAMPLE 
We used the data from a prospective national cohort, using the research database of the “Observatoire 
Sommeil de la Fédération de Pneumologie” (OSFP). The OSFP registry is a standardized web-based 
report, containing anonymized longitudinal data from patients with sleep disorders (21). We aimed to 
estimate the causal effect of compliance in the use of continuous positive airway pressure (CPAP) device 
on sleepiness symptoms among patients diagnosed with obstructive sleep apnoea. In the OSFP registry, 
the number of recorded visits per patient varies, so for simplicity, we focused on patients who had a visit 
within 3 months, 6 months and 1 year following the initiation of CPAP treatment in order to focus on the 
problem of missing records rather than sparse follow-up. Compliance was determined as an average use 
of CPAP >4hours per night within each time interval. The outcome was a continuous sleepiness score 
measured during the last visit using the Epworth Sleepiness Scale. Age, sex, body mass index, nocturia 
and presence of depression were considered as potential confounders in this study. The investigators 
intended to record updated values of body mass index, nocturia and depression at each visit; however, 
measurement was not always undertaken as planned. Patients could have one (or more) missing 
measurement(s) on at least one of these variables. Patients’ characteristics are described in appendix 
(Web Table 6). 
Out of 1,169 included patients, only 263 (22.8%) patients had a complete record (Web Table 7). Data is 
not MCAR since associations were observed between all potential confounders and the probability of 
having a complete record. However, a MAR mechanism is plausible in this setting. The MPA is not a 
suitable method for this analysis because of missing data on the CPAP exposure.  
Results are presented in Figure 4 and Web Table 8. Overall, we found no causal effect of CPAP 
compliance on sleepiness. Due to the relatively small sample size, IPMW led to very wide 95% 
confidence intervals. The 95% CI for LOCF is narrower, but does not account for the uncertainty around 
the imputed values. Furthermore, the assumption underlying the validity of LOCF is unlikely to hold 
here. As expected, all approaches gave similar results because confounding was not very strong (Web 
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Table 7). However, it illustrates the inefficiency of IPMW and the limitations of the MPA approach when 
exposure data are missing.  
DISCUSSION 
In this paper, we presented five methods to handle missing values in partially observed time-varying 
covariates in MSMs, identified situations in which they are appropriate to estimate unbiased causal 
effects, and illustrated how to implement these approaches in practice. We showed that, for the 
estimation of causal effects, CC analysis is often biased, unless data are MCAR. The validity of this 
assumption cannot be tested from the data (22), but violations of these assumptions can be detected by 
looking at associations between the probability of being a complete case and the variables available in 
the dataset. While the MCAR assumption is rarely plausible, we also showed that when missing values 
are MAR given treatment history and confounders, the bias of the CC estimates is usually small.  
LOCF leads to biased estimations of the treatment effects, unless missing values are in truth missing 
because they remained constant over time or when the previous measurement is used to adapt 
treatment (rather than the true - but missing - measurement). This assumption may hold in routinely 
collected data. For instance, GPs might not record a patient’s weight during a visit if it has not changed 
since the previous consultation. This assumption cannot be tested from the data but the plausibility of 
the assumption can be assessed using expert opinion, building on what has been proposed in 
randomised trials (23). Moreover, when using LOCF, the uncertainty around the single imputation of 
missing values is not accounted for (24). Although this is not an issue for categorical variables, it is 
problematic for continuous confounders where imputing exactly the previous measurement may lead to 
inappropriate certainty. 
As expected, MI led to unbiased estimates of the treatment effect when data were MCAR or MAR. 
When implementing MI, the outcome must be included in the imputation model and the treatment 
effect estimated in each imputed dataset and combined using Rubin’s rules, as recommended in settings 
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with a single time point (25). In our simulations and example, treatment and covariate values at all time 
points were included in the imputation model. With an increasing number of time points, issues of 
overfitting may arise. Two-fold multiple imputation has been proposed to circumvent this problem (26). 
Instead of using all the time-blocks in the imputation model, only the current and adjacent times are 
used, and therefore fewer parameters are to be estimated in the imputation model.  
MPA and IPMW have never been investigated in the context of MSMs. The MPA is unbiased when either 
the association between the partially observed confounder and the outcome or between the partially 
observed confounder and the subsequent treatment disappears among patients with a missing value for 
that confounder. Hence, the validity of this approach does not depend on the missingness mechanism 
but instead the relationship between covariates, treatment and outcome among patients with missing 
data. In routinely collected primary care data, this assumption is plausible when, for instance, the results 
of a blood test are used by the general practitioner to adapt treatment prescription. If these results are 
missing (i.e. not available to the general practitioner), they will not be used in the treatment decision: 
among patients with missing blood test results, the true (but unmeasured) value of the biological 
parameter is not directly associated with the treatment, and therefore the test result is no longer a 
confounder. The MPA is straightforward to implement but issues may arise when there are many 
missingness patterns. The MPA’s inability to accommodate missing data on the treatment and the 
outcome might limit its applicability, unlike IPMW, which includes only the complete records in the 
analysis, regardless of which variables have missing values. IPMW generally leads to unbiased estimates 
when data are MCAR and MAR. The exception is when missingness is directly affected by the outcome, 
because the outcome might be associated with treatment and confounder values at later time points, 
which are not accounted for in the missingness model to compute the weights. IPMW is also unbiased in 
scenarios where the MPA is unbiased because patients are censored at the first missing data, and 
therefore, no use is made of the information measured at later time points. However, IPMW is 
somewhat inefficient. This is explained by a loss in sample and by the multiplication of two weights (the 
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treatment weight and the missingness weight) that are both estimated with uncertainty, leading to 
highly variable treatment effect estimates. We recommend the use of IPMW in very large datasets, a 
situation in which MI would be highly computationally intensive. Furthermore, a limitation in the current 
implementation of IPMW is that missing data were considered as being monotone, that is, patients were 
excluded from the analysis even when the outcome was available at the end of follow-up. Recent 
developments on inverse weighting have included an extension to non-monotone missingness patterns 
(27), but it remains unclear how it could be transposed to MSMs. 
It is clear that no single missing data method can simultaneously handle different types of missingness 
mechanisms. However, in practice, missing values can occur on several variables according to different 
mechanisms. In such situations, it is crucial to understand the reasons for missingness to identify groups 
of variables with similar missingness mechanisms that could be handled altogether. For instance, in 
routinely collected data, some variables might not have been updated because their values remained 
unchanged, and some variables might be missing at random. A pragmatic approach would be to first use 
the LOCF on the first group of variables, and then multiply impute the variables from the second group. 
A more principled combination of methods has been proposed in simpler settings. Qu and Lipkovich (28) 
combined the MPA and MI for propensity score analysis with a single time point. Seaman and White 
proposed to combine MI and IPMW (29) but further investigation is needed before implementing these 
methods in MSMs. 
Although the role of the simulation was not to investigate the statistical properties of the five 
approaches in a broad range of settings, but to empirically illustrate the theoretical findings, the design 
of the simulations has several limitations. First, we focussed on a relatively simple setting with three 
time points and a few covariates. A plasmode simulation approach based on the sleep apnoea study 
would have been more realistic but would have not allowed us to investigate the “constant” and 
“differential” mechanisms of missing data. Second, we generated data with a continuous outcome only. 
While this was chosen because bias is more easily observed with continuous outcomes, our conclusions 
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will apply to binary and time-to-event outcomes; the validity of the methods relies on the missingness 
mechanism which is independent of the nature of the outcome. Similar conclusions would also hold had 
the outcome been measured repeatedly. With a larger number of partially observed confounders, 
sparse data in some missingness patterns may preclude use of the MPA approach. Moreover, in the 
presence of numerous confounders with interactions and non-linear effects, the functional form of the 
weight model might be harder to specify parametrically, and the obtained weights could be unstable. 
These problems may be alleviated by using more robust approaches (30) or statistical learning methods 
(31). Finally, the standard error of treatment effect estimates in our simulation study did not account for 
the uncertainty in the weight estimation, resulting in overly wide 95% confidence intervals. Non-
parametric bootstrap was used in our illustrative example but was too computationally demanding for 
use in simulations.  
In conclusion, the choice of the appropriate method(s) to handle partially observed confounders in 
MSMs must rely on a careful consideration of the reasons for missingness and whether missingness 
modifies the existing relationships among observed data. Causal diagrams may help in understanding 
the structure of the data and the relationships between variables when data are missing, and when data 
are observed. Although MI outperforms the other approaches when data are MAR, we presented two 
scenarios, encountered in routinely collected data, where MI leads to biased estimates of the treatment 
effect estimates but LOCF and the MPA might be suitable alternatives. Any analysis with missing data 
inevitably relies on assumptions about the missingness mechanisms or missingness patterns, which are 
often not made explicit. We therefore encourage researchers to clearly describe the assumptions under 
which their primary analysis is valid, and to perform sensitivity analyses to assess robustness of their 
results to departures from these postulated missingness mechanisms. 
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Table 1. Characteristics of the 5 missing data methods for partially observed time-varying confounders 
 
Method 
Missing data 
on … 
Assumptions 
Unbiased in 
MSMs when… 
Advantages Limitations 
Complete 
case  
Covariates 
Treatment 
Outcome 
Missing data are MCAR MCAR Straightforward 
May be inefficient 
because of the loss 
in sample size 
Last 
Observation 
Carried 
Forward  
Covariates 
Treatment 
Outcome 
except at 
baseline 
The true, but missing, 
value is the same as 
the last available 
measurement 
Constant 
Straightforward 
It can lead to too 
narrow confidence 
intervals 
OR 
Discards fewer 
patients from the 
analysis than CC 
Patients are 
discarded if 
baseline 
measurements are 
missing 
The treatment decision 
depends on the 
previous available 
measurement rather 
than the true 
(unobserved) one 
Multiple 
imputation  
Covariates 
Treatment 
Outcome 
Missing data are MAR
a
 MCAR 
MAR|A,L 
MAR|A,L,Y 
MAR|A,L,V 
Maintains the 
original sample size 
May be 
computationally 
intensive 
The imputation model 
is correctly specified 
Challenging for a 
large number of 
time points 
Inverse-
probability-
of-
missingness 
weighting  
Covariates 
Treatment 
Outcome 
Missing data are MAR 
given the treatment 
and the covariates, but 
not the outcome MCAR 
MAR|A,L 
MAR|A,L,V 
Constant 
Faster than MI for 
large datasets 
May be inefficient 
for small and 
moderate sample 
size The weight model is 
correctly specified 
Weights 
simultaneously 
address 
confounding and 
missing data 
Missingness 
Pattern 
Approach  
Covariates 
The partially observed 
covariate is no longer a 
confounder once 
missing 
Differential 
Relatively simple to 
implement 
Does not handle 
missing data on the 
exposure or 
outcome 
e.g. the treatment 
decision depends on 
the confounder value 
only when a 
measurement is 
available 
Assumptions do not 
relate to Rubin’s 
taxonomy so may 
work when 
standard methods 
do not 
Challenging when 
the number of 
missingness 
patterns is large 
CC: complete cases; MI: multiple imputation; MCAR: missing completely at random; MAR: missing at random; 
MNAR: missing not at random. 
 
a Extensions to accommodate MNAR exist but are challenging to apply in practice. 
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Figure 1. Causal graphs representing several possible scenarios for missing values. At each time, L1, L2 
are the two time-varying confounders, A is the time-varying treatment, Y is the outcome, V is an 
independent risk factor, and R is the missingness indicator. Diagrams represent scenarios in which 
missingness: A) occurs completely at random (MCAR); B) occurs when there has been no change since 
the previous measurement (Constant); C) occurs at random given the confounders and treatment 
(MAR|A,L); D) occurs at random given the confounders, treatment, and outcome (MAR|A,L,Y); E) occurs 
at random given the confounders, treatment, and independent risk factor F) depends on the treatment 
and confounders, but the association between the missing value and the subsequent treatment 
allocation no longer exists (Differential). Under F), the confounder only contributes to the treatment 
allocation decision when observed. 
 
Figure 2. Absolute bias of the treatment effect estimate at k=0 (A,D,G), k=1 (B,E,H) and k=2 (C, F,I) on full 
data and following the use of different missing data approach under the missing completely at random 
(A-C), Constant (D-F) and C Differential (G-I) missingness mechanisms. N=10000. 40% of missing data. 
CC: complete cases; LOCF: last observation carried forward; MPA: missing pattern approach; MI: multiple 
imputation; IPMW: inverse probability of missingness weighting. For multiple imputation, 10 imputed datasets 
were generated. 
 
Figure 3. Absolute bias of the treatment effect estimate at k=0 (A,D,G), k=1 (B,E,H) and k=2 (C, F,I)  on 
full data and following the use of different missing data approach under 3 scenarios of data missing at 
random: A-C) missing at random given the covariates and the treatment (MAR|A,L), D-F) given the 
covariates, the treatment and the outcome (MAR|A,L,Y) and G-I) given the covariates, the treatment 
and the independent risk factor (MAR|A,L,V). N=10000. 40% of missing data. 
CC: complete cases; LOCF: last observation carried forward; MPA: missing pattern approach; MI: multiple 
imputation; IPMW: inverse probability of missingness weighting. For multiple imputation, 10 imputed datasets 
were generated. 
 
Figure 4: Results of the illustrative example. Each point represents the difference in sleepiness scores at 
the end of the study (12 months) between compliers (CPAP use>=4 hours per night) and non-compliers 
(CPAP use<4 hours per night) at each of 3 time-points (3 months (squares), 6 months (circle) and 12 
months (triangles)). The vertical bars are the 95% confidence intervals. 
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